363 related articles for article (PubMed ID: 22373942)
1. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
Mason BJ; Crean R; Goodell V; Light JM; Quello S; Shadan F; Buffkins K; Kyle M; Adusumalli M; Begovic A; Rao S
Neuropsychopharmacology; 2012 Jun; 37(7):1689-98. PubMed ID: 22373942
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
[TBL] [Abstract][Full Text] [Related]
3. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.
Mariani JJ; Malcolm RJ; Mamczur AK; Choi JC; Brady R; Nunes E; Levin FR
Am J Drug Alcohol Abuse; 2016 May; 42(3):333-40. PubMed ID: 26962719
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
Furieri FA; Nakamura-Palacios EM
J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
Myrick H; Malcolm R; Randall PK; Boyle E; Anton RF; Becker HC; Randall CL
Alcohol Clin Exp Res; 2009 Sep; 33(9):1582-8. PubMed ID: 19485969
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
7. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Trigo JM; Lagzdins D; Rehm J; Selby P; Gamaleddin I; Fischer B; Barnes AJ; Huestis MA; Le Foll B
Drug Alcohol Depend; 2016 Apr; 161():298-306. PubMed ID: 26925704
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.
Sanders NC; Mancino MJ; Gentry WB; Guise JB; Bickel WK; Thostenson J; Oliveto AH
Exp Clin Psychopharmacol; 2013 Aug; 21(4):294-302. PubMed ID: 23855333
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
Gorelick DA
Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin for the treatment of substance use disorders.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Dec; 51(12):11-4. PubMed ID: 24712024
[TBL] [Abstract][Full Text] [Related]
11. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin for the treatment of alcohol use disorder.
Mason BJ; Quello S; Shadan F
Expert Opin Investig Drugs; 2018 Jan; 27(1):113-124. PubMed ID: 29241365
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
[TBL] [Abstract][Full Text] [Related]
14. Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients.
Kheirabadi GR; Ranjkesh M; Maracy MR; Salehi M
Addiction; 2008 Sep; 103(9):1495-9. PubMed ID: 18783503
[TBL] [Abstract][Full Text] [Related]
15. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.
Mason BJ; Light JM; Williams LD; Drobes DJ
Addict Biol; 2009 Jan; 14(1):73-83. PubMed ID: 18855801
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.
Brower KJ; Myra Kim H; Strobbe S; Karam-Hage MA; Consens F; Zucker RA
Alcohol Clin Exp Res; 2008 Aug; 32(8):1429-38. PubMed ID: 18540923
[TBL] [Abstract][Full Text] [Related]
17. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
[TBL] [Abstract][Full Text] [Related]
18. Importance of gabapentin dose in treatment of opioid withdrawal.
Salehi M; Kheirabadi GR; Maracy MR; Ranjkesh M
J Clin Psychopharmacol; 2011 Oct; 31(5):593-6. PubMed ID: 21869694
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
Schacht JP; Randall PK; Waid LR; Baros AM; Latham PK; Wright TM; Myrick H; Anton RF
Alcohol Clin Exp Res; 2011 Nov; 35(11):2030-8. PubMed ID: 21631542
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin's acute effect on mood profile -- a controlled study on patients with alcohol withdrawal.
Bonnet U; Specka M; Leweke FM; Nyhuis P; Banger M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):434-8. PubMed ID: 17178181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
